SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kazumi Yamasaki, Mayumi Tomohiro, Yumiko Nagao, Michio Sata, Toshiaki Shimoda, Kazuhiro Hirase, Satoshi Shirahama, Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients, BMC Gastroenterology, 2012, 12, 1, 139

    CrossRef

  2. 2
    Eiichi Tomita, Kazuki Ando, Jun-ichi Sugihara, Youichi Nishigaki, Tetsuya Yamada, Ryoko Ando, Masao Takemura, Mitsuru Seishima, Advantage of IFN-β/α2b same-day administration for ribavirin-intolerant patients with chronic hepatitis C, Hepatology Research, 2010, 40, 3
  3. 3
    Yoshihide Ueda, Yasutsugu Takada, Hironori Haga, Motoshige Nabeshima, Hiroyuki Marusawa, Takashi Ito, Hiroto Egawa, Koichi Tanaka, Shinji Uemoto, Tsutomu Chiba, Limited Benefit of Biochemical Response to Combination Therapy for Patients With Recurrent Hepatitis C After Living-Donor Liver Transplantation, Transplantation, 2008, 85, 6, 855

    CrossRef

  4. 4
    Masanori Ikeda, Nobuyuki Kato, Modulation of host metabolism as a target of new antivirals, Advanced Drug Delivery Reviews, 2007, 59, 12, 1277

    CrossRef

  5. 5
    Fabio Tinè, Massimo Attanasio, Francesca Russo, Luigi Pagliaro, A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis, Contemporary Clinical Trials, 2005, 26, 2, 179

    CrossRef

  6. 6
    Yasushi Shiratori, Haruhiko Yoshida, Masao Omata, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  7. 7
    Donglai Wu, Kenji Murakami, Nihong Liu, Yasuo Inoshima, Takashi Yokoyama, Takehiro Kokuho, Shigeki Inumaru, Tomio Matsumura, Takashi Kondo, Katsushige Nakano, Hiroshi Sentsui, EXPRESSION OF BIOLOGICALLY ACTIVE RECOMBINANT EQUINE INTERFERON-γ BY TWO DIFFERENT BACULOVIRUS GENE EXPRESSION SYSTEMS USING INSECT CELLS AND SILKWORM LARVAE, Cytokine, 2002, 20, 2, 63

    CrossRef

  8. 8
    Noboru Hirashima, Yoshihiro Matsumoto, Tomoyoshi Ohono, Yoshihide Kimura, Izumi Hasegawa, Ryuzo Ueda, Hepatic Fas Protein Expression Might Be a Predictive Factor for Hepatocellular Carcinoma Development in Patients With Chronic Hepatitis C Undergoing Interferon Therapy, Journal of Clinical Gastroenterology, 2002, 34, 3, 263

    CrossRef

  9. 9
    Vincent Leroy, Caroline De Traversay, Raphaelle Barnoud, Jean-Daniel Hartmann, Marilyne Baud, Denis Ouzan, Jean-Pierre Zarski, Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha, Journal of Hepatology, 2001, 35, 1, 120

    CrossRef

  10. 10
    T. Thévenot, C. Regimbeau, V. Ratziu, V. Leroy, P. Opolon, T. Poynard, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001, 8, 1
  11. 11
    Shih-Yen Lo, Hans Hsienhong Lin, Variations within hepatitis C virus E2 protein and response to interferon treatment, Virus Research, 2001, 75, 2, 107

    CrossRef

  12. 12
    Akeri Mitsuda, Takeaki Suou, Yujiro Ikuta, Hironaka Kawasaki, Changes in serum tissue inhibitor of matrix metalloproteinase-1 after interferon alpha treatment in chronic hepatitis C, Journal of Hepatology, 2000, 32, 4, 666

    CrossRef

  13. 13
    Nina Singh, THE CURRENT MANAGEMENT OF INFECTIOUS DISEASES IN THE LIVER TRANSPLANT RECIPIENT, Clinics in Liver Disease, 2000, 4, 3, 657

    CrossRef

  14. 14
    Peter Simmonds, Hepatitis C, 2000,

    CrossRef

  15. 15
    Antonio Craxï, Calogero Cammà, Marco Giunta, Definition of response to antiviral therapy in chronic hepatitis C, Journal of Hepatology, 1999, 31, 160

    CrossRef

  16. 16
    Joël Fort, Christophe Pilette, Nary Veal, Frédéric Oberti, Yves Gallois, Olivier Douay, Jean Rosenbaum, Paul Calès, Effects of long-term administration of interferon α in two models of liver fibrosis in rats, Journal of Hepatology, 1998, 29, 2, 263

    CrossRef

  17. 17
    Johannes T. Brouwer, Frederik Nevens, Bernhard Kleter, Andre Elewaut, Michael Alder, Reginald Brenard, Rob A.F.M. Chamuleau, Peter P. Michielsen, Jean Pirotte, Marc L. Hautekeete, Joseph Weber, Nadine Bourgeois, Bettina E. Hansen, Carolien M. Bronkhorst, Fibo J.W. ten Kate, Rudolf A. Heijtink, Johan Fevery, Solko W. Schalm, Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients, Journal of Hepatology, 1998, 28, 6, 951

    CrossRef

  18. 18
    A. Vince, D. Palmović, N. Kutela, Z. Sonicky, T. Jeren, M. Radovani, HCV genotypes in patients with chronic hepatitis C in Croatia, Infection, 1998, 26, 3, 173

    CrossRef

  19. 19
    Timothy Allen Morton, Gabor David Kelen, Hepatitis C, Annals of Emergency Medicine, 1998, 31, 3, 381

    CrossRef

  20. 20
    Eiichi Imano, Tsutomu Kanda, Yoshitaka Ishigami, Minoru Kubota, Masahiko Ikeda, Munehide Matsuhisa, Ryuzo Kawamori, Yoshimitsu Yamasaki, Interferon induces insulin resistance in patients with chronic active hepatitis C, Journal of Hepatology, 1998, 28, 2, 189

    CrossRef

  21. 21
    F. Piccinino, F.M. Felaco, E. Sagnelli, L. Aprea, V. Messina, G. Pasquale, P. Filippini, C. Scolastico, Long-term lymphoblastoid interferon-α therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFNα treatment, Research in Virology, 1998, 149, 5, 283

    CrossRef

  22. 22
    Françoise Degos, Véronique Daurat, Sylvie Chevret, Sophie Gayno, Anne Bastie, Ghassan Riachi, Isabelle Bartolomei-Portal, Karl Barange, Joseph Moussalli, Sylvie Naveau, François Bailly, Philippe Chaumet-Riffaud, Claude Chastang, Reinforced regiment of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomized trial, Journal of Hepatology, 1998, 29, 2, 224

    CrossRef

  23. 23
    Manal F. Abdelmalek, M. Edwyn Harrison, John B. Gross, John J. Poterucha, Andrea A. Gossard, James R. Spivey, Jorge Rakela, Keith D. Lindor, Treatment of Chronic Hepatitis C With Interferon With or Without Ursodeoxycholic Acid, Journal of Clinical Gastroenterology, 1998, 26, 2, 130

    CrossRef

  24. 24
    Akinori Kasahara, Norio Hayashi, Kiyoshi Mochizuki, Masahide Oshita, Kazuhiro Katayama, Michio Kato, Manabu Masuzawa, Harumasa Yoshihara, Masafumi Naito, Takeshi Miyamoto, Atsuo Inoue, Akira Asai, Taizou Hijioka, Hideyuki Fusamoto, Takenobu Kamada, Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C, Journal of Hepatology, 1997, 26, 3, 574

    CrossRef

  25. 25
    Kazuyoshi Ohkawa, Nobukazu Yuki, Yoshiyuki Kanazawa, Keiji Ueda, Eiji Mita, Yutaka Sasaki, Akinori Kasahara, Norio Hayashi, Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro, Journal of Hepatology, 1997, 27, 1, 78

    CrossRef

  26. 26
    Kazuyoshi Ohkawa, Norio Hayashi, Nobukazu Yuki, Akinori Kasahara, Masahide Oshita, Kiyoshi Mochizuki, Kazuhiro Katayama, Hideyuki Fusamoto, Michio Kato, Manabu Masuzawa, Harumasa Yoshihara, Tomoyuki Mukuda, Takenobu Kamada, Disease stage of chronic hepatitis C assessed by both peritoneoscopic and histologic findings and its relationship with response to interferon therapy, Gastrointestinal Endoscopy, 1997, 45, 2, 168

    CrossRef

  27. 27
    Stephen D.H.P. Malnick, Hemda Schmilovitz-Weiss, Editorial: Interferon Therapy for Chronic HCV Hepatitis: Trick or Treat?, Journal of Clinical Gastroenterology, 1997, 25, 1, 310

    CrossRef

  28. 28
    Giorgio Saracco, Elisabetta Borghesio, Pietro Mesina, Antonello Solinas, Claudia Spezia, Franco Macor, Vittorio Gallo, Livio Chiandussi, Carlo Donada, Valter Donadon, Fulvio Spirito, Alessandra Mangia, Angelo Andriulli, Giorgio Verme, Mario Rizzetto, Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C, Journal of Hepatology, 1997, 27, 1, 56

    CrossRef

  29. 29
    Y. Imai, S. Kawata, S. Tamura, N. Ito, K. Seki, M. Nishiuchi, Y. Shinji, K. Kiriyama, S. Himeno, Y. Minami, T. Kashihara, F. Kawakami, H. Maeda, I. Yabuuchi, M. Nishioka, Y. Shirai, K. Fukuda, S. Kiso, T. Ito, M. Igura, Y. Doi, Y. Matsuzawa, Recombinant interferon-α-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study, Liver, 1997, 17, 2
  30. 30
    Calogero Cammá, Marco Giunta, Cristina Linea, Luigi Pagliaro, The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis, Journal of Hepatology, 1997, 26, 6, 1187

    CrossRef

  31. 31
    Dominik M. Alscher, J. Christian Bode, Therapie der Hepatitis C, Medizinische Klinik, 1997, 92, 3, 147

    CrossRef

  32. 32
    Silvio Magrin, Antonio Craxi, Carmelo Fabiano, Liliana Marino, Germana Fiorentino, Oreste Lo Iacono, Riccardo Volpes, Vito Di Marco, Piero Almasio, Alessandra Vaccaro, Mickey S. Urdea, Judith C. Wilber, Celestino Bonoura, Fabrizio Gianguzza, Vincenza Capursi, Salvatore Filiberti, Lieven Stuyver, Luigi Pagliaro, HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy), Journal of Hepatology, 1996, 25, 5, 583

    CrossRef

  33. 33
    Gary L. Davis, Interferon therapy for chronic hepatitis C, Baillière's Clinical Gastroenterology, 1996, 10, 2, 289

    CrossRef

  34. 34
    Rocco Misiani, Piermario Bellavita, Mixed Cryoglobulinaemia, Clinical Immunotherapeutics, 1996, 5, 2, 115

    CrossRef

  35. 35
    Vincent Agnello, Paul L. Romain, MIXED CRYOGLOBULINEMIA SECONDARY TO HEPATITIS C VIRUS INFECTION, Rheumatic Disease Clinics of North America, 1996, 22, 1, 1

    CrossRef

  36. 36
    Takeshi Okanoue, Shinichi Sakamoto, Yoshito Itoh, Masahito Minami, Koichiro Yasui, Masafumi Sakamoto, Kenichi Nishioji, Tatsuo Katagishi, Yoshihiro Nakagawa, Hisashi Tada, Yoshihiko Sawa, Masayuki Mizuno, Keizo Kagawa, Kei Kashima, Side effects of high-dose interferon therapy for chronic hepatitis C, Journal of Hepatology, 1996, 25, 3, 283

    CrossRef

  37. 37
    Hari S. Conjeevaram, James E. Everhart, Jay H. Hoofnagle, Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C, Hepatology, 1995, 22, 4
  38. 38
    Nobukazu Yuki, Norio Hayashi, Kazuyoshi Ohkawa, Hideki Hagiwara, Masahide Oshita, Kazuhiro Katayama, Yutaka Sasaki, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada, The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C, Hepatology, 1995, 22, 2
  39. 39
    Robert P Myers, Corinne Regimbeau, Thierry Thevenot, Vincent Leroy, Philippe Mathurin, Pierre Opolon, Jean Pierre Zarski, Thierry Poynard, Interferon for interferon naive patients with chronic hepatitis C, The Cochrane Library,